SCHEMBL17769501

SCHEMBL17769501

Cc1cc(-c2cc(C)c3c(n2)N(C(=O)Nc2cccnc2)C2CCCN3C2)ccn1

nearest known ligand 0.43

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 2/20 0.43
▸ BTK Q06187 1/20 0.40
▸ ABL1 P00519 3/20 0.38
▸ BCR P11274 3/20 0.38
▸ ALDH1A1 P00352 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ PIM1 P11309 2/20 0.37
▸ HTR2A P28223 7/20 0.37
▸ HTR2C P28335 7/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ PORCN Q9H237 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17778627 1.00 GRM5 (0.43) GRM5BTKABL1BCRALDH1A1
SCHEMBL17778649 0.95 GRM5 (0.41) GRM5ABL1BCRPIM1HTR2A
SCHEMBL19689690 0.95 GRM5 (0.41) GRM5ABL1BCRPIM1HTR2A
SCHEMBL20733261 0.89 KMT2A (0.42) BTKABL1BCRALDH1A1MAPT
SCHEMBL16776482 0.89 ALDH1A1 (0.42) GRM5BTKABL1BCRALDH1A1
SCHEMBL16754430 0.88 HTR2A (0.39) ALDH1A1HTR2AHTR2CKMT2A
SCHEMBL17778603 0.85 ALDH1A1 (0.40) GRM5BTKALDH1A1MAPTHTR2A
SCHEMBL17778469 0.84 ALDH1A1 (0.42) BTKALDH1A1MAPTHTR2AHTR2C
SCHEMBL19689778 0.84 HTR2C (0.41) ALDH1A1MAPTHTR2AHTR2C
SCHEMBL17778392 0.84 HTR2A (0.37) ALDH1A1HTR2AHTR2CPORCN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3221322-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS Glaxosmithkline Intellectual Property (No. 2) Limited (GB) 2017-09-27 — — EP disclosed
WO-2016079711-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2016-05-26 — — WO disclosed
Send feedback